Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1977 2
1979 2
1980 3
1981 3
1982 1
1984 4
1985 4
1987 1
1988 1
1990 1
1991 1
1993 1
1996 1
1997 1
1999 1
2000 2
2003 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Optimizing the management of differentiated thyroid cancer.
Mallick UK, Lucraft H, Proud G, Perros P, Fenwick J, Kendall-Taylor P, Johnson S, Lennard T, Ball S, James RA, Douglas F, Weightman DR. Mallick UK, et al. Among authors: weightman dr. Clin Oncol (R Coll Radiol). 2000;12(6):363-4. doi: 10.1053/clon.2000.9195. Clin Oncol (R Coll Radiol). 2000. PMID: 11202089 No abstract available.
Bromocriptine therapy in acromegaly.
Sachdev Y, Gomez-Pan A, Tunbridge WM, Duns A, Weightman DR, Hall R, Goolamali SK. Sachdev Y, et al. Among authors: weightman dr. Lancet. 1975 Dec 13;2(7946):1164-8. doi: 10.1016/s0140-6736(75)92655-0. Lancet. 1975. PMID: 53655 Clinical Trial.
Brain oestradiol and testosterone levels in Alzheimer's disease.
Twist SJ, Taylor GA, Weddell A, Weightman DR, Edwardson JA, Morris CM. Twist SJ, et al. Among authors: weightman dr. Neurosci Lett. 2000 May 26;286(1):1-4. doi: 10.1016/s0304-3940(00)01078-8. Neurosci Lett. 2000. PMID: 10822138
Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.
Scanlon MF, Gomez-Pan A, Mora B, Cook DB, Dewar JH, Hildyard A, Weightman DR, Evered DC, Hall R. Scanlon MF, et al. Among authors: weightman dr. Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):191S-197S. doi: 10.1111/j.1365-2125.1977.tb05752.x. Br J Clin Pharmacol. 1977. PMID: 911652 Free PMC article.
34 results